Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance Journal Articles Refereed uri icon

Overview

Published in

  • Cancer Biology & Therapy

Time

Date/time value

  • 2005

Identity

Digital Object Identifier (DOI)

  • 10.4161/cbt.4.9.1911

Additional Document Info

Parent Title

  • CANCER BIOLOGY & THERAPY

Volume

  • 4

Issue

  • 9

Publisher

  • Landes Bioscience